in pictures and a few words
What it is and why it matters
Glutathione is a substance found in every cell. It is called the cells’ main protector against damage.
- It is built from three amino acids — the “building blocks” of protein
- The liver has the most of it: it helps the liver neutralise harmful substances
- Glutathione also matters for the immune system
How the liver neutralises harm
The liver neutralises harmful substances in three steps. In the first step a substance can briefly become more harmful, so the second step has to keep up with the first.
- Step 1: the liver changes the harmful substance
- Step 2: protectors latch on to it, glutathione among the main ones; this makes the substance safer
- Step 3: the neutralised substance leaves with bile into the gut or with urine via the kidneys
Why glutathione runs low
In a healthy cell almost all glutathione is in its working form. Under overload it is used up faster than the cell can restore it.
- Long-lasting infections and inflammation, alcohol, heavy metals: mercury, lead, cadmium
- Paracetamol: the liver neutralises its harmful by-product with glutathione
- Age and a shortage of raw materials: protein “building blocks”, selenium, vitamin B6
Acetylcysteine feeds glutathione
Acetylcysteine is a form of the amino acid that most determines how much glutathione a cell can make. It has been used in medicine for over 50 years.
- It thins mucus and saves the liver in paracetamol poisoning
- Taken by mouth, it raises glutathione inside cells
- Usually 600 mg twice a day on an empty stomach; older people in a study got more, by body weight
Ready-made glutathione: which form
A single glutathione capsule barely raises it in the blood. But taken daily for months, its stores grow.
- Inside fat bubbles it is protected; in a small pilot study stores rose within 2 weeks
- It is taken when a shortage is confirmed: 500–1000 mg in the morning on an empty stomach
- A drip goes straight into the blood; only in a clinic and under a doctor’s supervision
Basic daily support
The daily set from the article: acetylcysteine and the substances a cell uses to build and restore glutathione.
- Glycine — 3–5 g a day, can be taken before bed; selenium — 200 mcg a day
- Vitamin C — 1000 mg twice a day: returns glutathione to its working form
- Alpha-lipoic acid — 300–600 mg a day: also restores glutathione
Important. Grapefruit, St John’s wort, and supplements with green tea and turmeric change how medicines work. If you take medicines, tell your doctor.
Food and alcohol
Foods rich in sulphur support glutathione production.
- Eggs, garlic, onions, cabbage and other vegetables of its family
- Food helps partly: with a confirmed shortage, food alone is not enough
- Even moderate amounts of alcohol lower glutathione in the liver
Important. With alcohol dependence, supplements are pointless without giving up alcohol; the liver is treated together with a doctor.
The gut finishes the job
Part of what has been neutralised goes with bile into the gut. If bowel movements are infrequent, gut bacteria can “unpack” the substances, and they return to the blood.
- Fibre — more than 30 g a day — binds them and carries them out
- Regular bowel movements are an important part of clearing
- Fermented milk products and fermented foods affect the make-up of these bacteria
Who should see a doctor first
Before starting any regimen, you need a specialist’s advice. Especially in these cases.
- Pregnancy, breastfeeding, children under 12 — standard adult regimens are not for them
- Asthma: high doses of acetylcysteine can cause airway spasm; start with 600 mg a day
- Chemotherapy: any antioxidants only with your oncologist’s approval
Important. Suspected paracetamol overdose — go to hospital right away. Acetylcysteine capsules at home do not help.
In one sentence
Glutathione helps the liver neutralise harmful substances. It is supported by its raw materials, sulphur-rich food, fibre and less alcohol, and a supplement plan is agreed with a doctor.
What Is Glutathione and Why It Matters
Glutathione (GSH) is a tripeptide composed of three amino acids: glutamic acid, cysteine, and glycine. It is present in every cell, but the liver contains the highest concentrations — up to 5-10 mM. According to a comprehensive review in Antioxidants & Redox Signaling (2018), glutathione is the most potent intracellular antioxidant and plays a central role in maintaining redox homeostasis.
The key indicator of cellular health is the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG). In healthy cells, this ratio is approximately 100:1. Under oxidative stress, toxic exposure, chronic inflammation, or aging, the balance shifts toward GSSG, triggering lipid peroxidation, DNA damage, and apoptosis.
The Three Phases of Hepatic Detoxification
Phase I: Oxidation (Cytochrome P450 System)
The cytochrome P450 (CYP450) enzyme family serves as the liver's first line of defense. These enzymes perform oxidation, reduction, and hydrolysis reactions, converting fat-soluble toxins into more reactive intermediate metabolites. CYP3A4, CYP2D6, CYP1A2, and CYP2C9 are the primary isoforms, collectively metabolizing up to 80% of all pharmaceutical drugs (Annual Review of Pharmacology and Toxicology, 2018).
The Phase I paradox: intermediate metabolites are often more toxic than the parent compounds. They generate free radicals that damage hepatocyte membranes. This is precisely why Phase II must operate in synchrony with Phase I — any imbalance creates a dangerous accumulation of reactive intermediates.
Phase II: Conjugation
Reactive intermediates from Phase I are bound to endogenous molecules, becoming water-soluble and less toxic. Key conjugation reactions include: glutathione S-transferase (GST) conjugation, glucuronidation (UGT), sulfation (SULT), methylation (COMT, TPMT), acetylation (NAT), and amino acid conjugation (glycine, taurine).
GST conjugation is one of the most critical Phase II reactions. The GST enzyme couples glutathione with electrophilic metabolites, neutralizing them. A meta-analysis in PLoS ONE (2014) showed that polymorphisms in GSTM1 and GSTT1 genes (null genotypes) are associated with increased cancer risk due to reduced detoxification capacity.
Phase III: Elimination (Transport)
Conjugated metabolites must be efficiently exported from the cell. Phase III is mediated by ABC (ATP-binding cassette) transporter proteins: P-glycoprotein (MDR1/ABCB1), MRPs (multidrug resistance-associated proteins), and BCRP. These transporters pump conjugates into bile (for intestinal excretion) or blood (for renal excretion).
Phase III dysfunction leads to intracellular accumulation of conjugated toxins — a mechanism underlying drug-induced liver injury. Research in Hepatology (2019) demonstrated that genetic variants of ABCB1 and ABCC2 transporters significantly affect elimination rates.
Why Glutathione Levels Decline
Chronic oxidative stress consumes glutathione faster than cells can regenerate it. Major causes of depletion include: - Chronic infections and inflammation (increased GSH consumption by immune cells) - Heavy metal exposure (mercury, lead, cadmium bind directly to GSH) - Alcohol (acetaldehyde, the toxic metabolite, requires GSH for detoxification) - Acetaminophen/paracetamol (forms NAPQI, neutralized by glutathione) - Aging (after 45, GSH synthesis declines 10-15% per decade) - Precursor deficiency: cysteine, glycine, glutamic acid, selenium, vitamin B6
NAC: The Key Glutathione Precursor
N-acetylcysteine (NAC) is the acetylated form of L-cysteine, which is the rate-limiting factor in glutathione synthesis. NAC has been used clinically for over 50 years: as a mucolytic, as the antidote for acetaminophen overdose, and as a protectant against contrast-induced nephropathy.
A meta-analysis in Advances in Pharmacological Sciences (2019) confirmed that oral NAC (600-1200 mg/day) significantly increases intracellular glutathione levels. In Am J Clin Nutr (2011), NAC and glycine dosed by body weight (about 130 and 100 mg/kg/day) restored erythrocyte glutathione in 8 older adults to the level of young volunteers within 2 weeks.
Glutathione Forms: Oral, Liposomal, and Intravenous
Standard oral glutathione is partly degraded in the gut; a single 3 g dose does not raise plasma GSH (Witschi 1992). Taken daily it accumulates: in an RCT (54 adults, 6 months) 1000 mg/day raised erythrocyte, plasma and lymphocyte GSH by 30–35% (Richie, Eur J Nutr 2015).
| Form | Note |
|---|---|
| Oral | +30–35% in 6 months (1000 mg) |
| Liposomal | +25–40% in 2 weeks (pilot) |
| Intravenous | 100% bioavailability |
Liposomal glutathione is encapsulated in phospholipid vesicles that protect the molecule from GI degradation. In a pilot (12 adults, 500–1000 mg/day, no control group) whole-blood GSH rose by up to 40% and erythrocyte GSH by 25% within 2 weeks (Sinha, Eur J Clin Nutr 2018).
Intravenous glutathione (IV GSH) provides 100% bioavailability and immediate elevation of plasma levels. Used in integrative clinics for intensive detoxification, neuroprotection, and post-chemotherapy recovery. Typical dose: 600-2400 mg per infusion, administered 1-3 times per week.
The Milano Cocktail is an intravenous formula developed in Italian anti-aging clinics: glutathione 600 mg + vitamin C 5000 mg + alpha-lipoic acid 600 mg + B-complex vitamins. The combination provides synergistic antioxidant and detoxification effects by recycling glutathione through ascorbic acid and alpha-lipoic acid.
Glutathione Restoration Protocol
Diagnostic Assessment
- Erythrocyte glutathione (GSH/GSSG ratio) — the most accurate marker of intracellular stores
- Organic Acids Test (OAT) — pyroglutamic acid is elevated in GSH deficiency
- 8-OHdG — marker of oxidative DNA damage
- Genetic testing — GSTM1, GSTT1, GSTP1, GPX1 polymorphisms determine individual requirements
Frequently Asked Questions
Can diet alone raise glutathione levels? Partially. Foods rich in sulfur-containing amino acids (eggs, garlic, cruciferous vegetables, onions) support GSH synthesis. However, with confirmed deficiency, diet alone is insufficient — targeted supplementation is needed.
NAC or liposomal glutathione — which is better? NAC is a precursor the body uses to synthesize its own GSH. Liposomal glutathione is the preformed molecule. For a long-term strategy, the optimal approach is combining daily NAC with periodic liposomal GSH courses.
Is NAC safe for asthma patients? Use with caution. High doses of NAC (>1800 mg/day) may trigger bronchospasm in some asthma patients. Start with 600 mg/day and titrate.
How often should IV glutathione be administered? Standard course: 1-2 times per week for 4-8 weeks. Maintenance: once every 2-4 weeks. Always under physician supervision.
Does alcohol affect glutathione levels? Significantly. Even moderate consumption (2-3 drinks) reduces hepatic GSH by 20-30%. Regular drinking creates chronic GSH deficiency, accelerating the development of alcoholic liver disease.
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment protocol.
🌀
Genotype-Stratified Interpretation of Detoxification Polymorphisms
The article recommends testing GSTM1, GSTT1, GSTP1, and GPX1 polymorphisms but does not describe how the genotype alters management. Each variant has measurable functional consequences that justify specific intervention emphasis.
GSTM1 null (deletion) is present in approximately 40–50% of European populations and up to 60% of East Asian populations. Carriers have absent GSTM1 enzyme activity, reducing conjugation capacity for polycyclic aromatic hydrocarbons, benzene metabolites, and several chemotherapy agents. Meta-analyses show GSTM1-null carriers have an increased risk of bladder cancer, lung cancer in smokers, and worse outcomes with platinum-based chemotherapy. For these patients, environmental exposure reduction — air filtration, water filtration, and avoidance of grilled or smoked meats — has higher yield than supplement intensification.
GSTT1 null occurs in 15–25% of European and 35–60% of Asian populations. Carriers have impaired conjugation of small reactive metabolites including dichloromethane, ethylene oxide, and certain therapeutic alkylating agents. Combined GSTM1/GSTT1 null genotype magnifies risk; these individuals should avoid solvent occupational exposure and benefit disproportionately from cruciferous-vegetable-derived sulforaphane, which upregulates compensatory Nrf2-driven enzymes.
GSTP1 Ile105Val (rs1695) alters substrate specificity and is associated with reduced activity for hydrophobic electrophiles. Val/Val homozygotes have attenuated response to oxidative stress but, paradoxically, sometimes better response to specific chemotherapies because tumor cells share the deficit. Clinical relevance is highest in patients with concurrent inflammatory disease or NAFLD.
GPX1 Pro198Leu (rs1050450) reduces glutathione peroxidase activity by approximately 30% in Leu/Leu carriers and is associated with cardiovascular and oncologic risk. Selenium status becomes rate-limiting: targeting plasma selenium of 120–150 µg/L through selenomethionine 200 µg/day is more effective in these carriers than in wild-type individuals.
Genotyping does not replace functional assessment; it stratifies the risk-benefit ratio of intensified intervention. A patient with normal GSH/GSSG, normal 8-OHdG, and GSTM1-null genotype does not require aggressive supplementation — only sustained exposure avoidance.
🌀
Monitoring Schedule, Stopping Rules, and Safety Endpoints
A protocol without follow-up is incomplete. NAC and IV glutathione protocols require structured monitoring because both efficacy and toxicity are dose- and duration-dependent.
IV glutathione 600–2400 mg, 1–3 times weekly: Pre-infusion checks should include electrolytes (especially for the Milano cocktail containing vitamin C 5 g, which can precipitate calcium oxalate stones in predisposed patients), creatinine, and a G6PD screen in patients of Mediterranean, African, or Southeast Asian ancestry. High-dose ascorbate in G6PD-deficient individuals can precipitate hemolytic crisis. Discontinue IV protocols if liver enzymes rise above 2× baseline or if the patient develops sulfur-related odor intolerance, headache, or hypotension during infusion.
🌀
Contraindications and Clinically Significant Drug Interactions
The original article briefly mentions caution with NAC in asthma but does not enumerate the broader contraindication set, which is clinically consequential.
🌀
Differential Diagnosis: When Low Glutathione Is the Cause vs. a Consequence
Functional medicine literature often frames glutathione depletion as the upstream lesion, but in many clinical contexts low GSH is a downstream biomarker of an unaddressed primary process. Distinguishing these scenarios prevents indefinite supplementation that fails to resolve symptoms.
Primary glutathione synthesis defects are rare but real. Glutathione synthetase deficiency, glutamate-cysteine ligase deficiency, and 5-oxoprolinase deficiency are inborn errors presenting in childhood with hemolytic anemia, metabolic acidosis, and neurological symptoms. Adult-onset functional cysteine deficiency from chronic dietary inadequacy, malabsorption (post-bariatric surgery, celiac disease, inflammatory bowel disease), or methylation cycle blocks (severe B12, folate, or B6 deficiency) represents an acquired form. These patients respond directly to precursor supplementation.
Glutathione depletion as a consequence occurs in: active chronic infection (Epstein-Barr reactivation, chronic hepatitis B/C, HIV, tuberculosis, Lyme co-infections), uncontrolled diabetes with HbA1c above 8.5%, ongoing heavy metal exposure (occupational, dental amalgam in symptomatic individuals, contaminated water), persistent mold biotoxin exposure, untreated obstructive sleep apnea with nocturnal hypoxia, and chronic NSAID, acetaminophen, or alcohol use. In all of these, supplementing glutathione without removing the upstream driver yields transient biomarker improvement followed by regression.
The redox framework is a powerful clinical tool, but it is a window into systemic biology, not a closed therapeutic loop. Restoring glutathione is necessary in many cases and sufficient in few.
Key facts
- Glutathione (GSH) is a tripeptide of glutamic acid, cysteine, and glycine; the liver holds the highest levels, up to 5–10 mM.
- In healthy cells the reduced-to-oxidized glutathione (GSH/GSSG) ratio is about 100:1.
- Hepatic detox runs in three phases: oxidation (CYP450), conjugation, and elimination via ABC transporters.
- Oral NAC (600–1200 mg/day) significantly raises intracellular glutathione and has been used clinically for over 50 years.
- Standard oral glutathione 1000 mg/day raised blood GSH by 30–35% over 6 months; liposomal GSH did so by 25–40% within 2 weeks in a small pilot.




